ARCHIVES

ZBB Considered Useless By NCI Staff (Privately)’ New Approach Groups Program Into Four Categories

This article is from The Cancer Letter archive.

Vol. 04 No. 40 | October 6, 1978

Download PDF Visit The Full Archive

Related Articles

Oncology ManagementL Tax-Exempt Bonds Issued To Expand UPCI; Sentillion, Dua Partner on Info System

March 5, 1999

ACS Says NCI Needs $1.1 Billion, Cites Progress In Prevention, Control

April 29, 1977

CMS Considering Regulatory Standards for Drug Company Bundling of Products.

October 20, 2006

Combine Phase 1-2, Abolish DRG, Slash Indirect Costs, Garb Tells Congress

November 27, 1981

DCBD Board Okays Concept For New Cytogenetics RFA

August 3, 1984

Charles Moertel, Mayo Clinic Investigator, Advocate Of Rigorous Trials, Dead At 66

July 8, 1994